BIONET Statistics

Total Valuation

BIONET has a market cap or net worth of TWD 4.07 billion. The enterprise value is 3.72 billion.

Market Cap	4.07B
Enterprise Value	3.72B

Important Dates

The next estimated earnings date is Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	Sep 19, 2024

Share Statistics

BIONET has 50.72 million shares outstanding. The number of shares has decreased by -0.16% in one year.

Current Share Class	n/a
Shares Outstanding	50.72M
Shares Change (YoY)	-0.16%
Shares Change (QoQ)	+0.07%
Owned by Insiders (%)	9.41%
Owned by Institutions (%)	0.60%
Float	40.26M

Valuation Ratios

The trailing PE ratio is 72.66.

PE Ratio	72.66
Forward PE	n/a
PS Ratio	3.44
PB Ratio	3.25
P/TBV Ratio	3.33
P/FCF Ratio	53.60
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 42.05, with an EV/FCF ratio of 48.97.

EV / Earnings	66.79
EV / Sales	3.16
EV / EBITDA	42.05
EV / EBIT	70.69
EV / FCF	48.97

Financial Position

The company has a current ratio of 4.25, with a Debt / Equity ratio of 0.04.

Current Ratio	4.25
Quick Ratio	3.95
Debt / Equity	0.04
Debt / EBITDA	1.09
Debt / FCF	1.27
Interest Coverage	56.36

Financial Efficiency

Return on equity (ROE) is 3.40% and return on invested capital (ROIC) is 1.76%.

Return on Equity (ROE)	3.40%
Return on Assets (ROA)	1.33%
Return on Capital (ROIC)	1.76%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.48
Inventory Turnover	7.44

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +47.11% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+47.11%
50-Day Moving Average	89.44
200-Day Moving Average	89.14
Relative Strength Index (RSI)	37.47
Average Volume (20 Days)	418,579

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BIONET had revenue of TWD 1.18 billion and earned 55.72 million in profits. Earnings per share was 1.11.

Revenue	1.18B
Gross Profit	648.00M
Operating Income	52.64M
Pretax Income	83.63M
Net Income	55.72M
EBITDA	78.28M
EBIT	52.64M
Earnings Per Share (EPS)	1.11

Full Income Statement

Balance Sheet

The company has 1.35 billion in cash and 96.80 million in debt, giving a net cash position of 1.25 billion or 24.62 per share.

Cash & Cash Equivalents	1.35B
Total Debt	96.80M
Net Cash	1.25B
Net Cash Per Share	24.62
Equity (Book Value)	2.15B
Book Value Per Share	24.71
Working Capital	1.36B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 165.81 million and capital expenditures -89.82 million, giving a free cash flow of 75.99 million.

Operating Cash Flow	165.81M
Capital Expenditures	-89.82M
Free Cash Flow	75.99M
FCF Per Share	1.50

Full Cash Flow Statement

Margins

Gross margin is 55.02%, with operating and profit margins of 4.47% and 4.73%.

Gross Margin	55.02%
Operating Margin	4.47%
Pretax Margin	7.10%
Profit Margin	4.73%
EBITDA Margin	6.65%
EBIT Margin	4.47%
FCF Margin	6.45%

Dividends & Yields

This stock pays an annual dividend of 0.66, which amounts to a dividend yield of 0.82%.

Dividend Per Share	0.66
Dividend Yield	0.82%
Dividend Growth (YoY)	9.05%
Years of Dividend Growth	4
Payout Ratio	n/a
Buyback Yield	0.16%
Shareholder Yield	0.98%
Earnings Yield	1.38%
FCF Yield	1.87%

Dividend Details

Stock Splits

The last stock split was on September 19, 2024. It was a forward split with a ratio of 1.070923771.

Last Split Date	Sep 19, 2024
Split Type	Forward
Split Ratio	1.070923771

Scores

BIONET has an Altman Z-Score of 3.97.

Altman Z-Score	3.97
Piotroski F-Score	n/a